At each center, we documented whether sedation, analgesia, or NMBs were administered using a local protocol.
Intramuscular injections using sterile technique were administered using 1-mL insulin syringes.
These data were administered using AC-STB software from Akkaya company, Köln, Germany [35].
The injections were administered using a 22-gauge, 1.5" needle (Magellan®).
Interviews were administered using a combination of computer-assisted personal interviewing and audio computer-assisted self-interviewing.
The compounds were administered using a Latin-square design 45 min prior to the weekly test sessions.
Four tasks were administered using a classical pre-test/training/post-test design: listening comprehension, reading comprehension, vocabulary and comprehension monitoring.
Measures of physical health, role quality, and psychological well-being previously used to test relationships among the variables in women with chronic illness were administered using a face-to-face interview format.
Intramuscular injections were administered using a sterile 30-gauge, 0.5 inch needle and 0.2 ml (saline dilution) of onabotulinum toxin A (5 U) or placebo at each site, except for the trapezius where we administered 0.4 ml of onabotulinum toxin A (10 U).
The tasks were administered using the Expe6 software package [9].
Nine of the ten subtests were administered using alternate items.
